Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review

The efficacy of SARS-CoV-2 vaccination in patients with hematological malignancies (HM) appears limited due to disease and treatment-associated immune impairment. We conducted a systematic review of prospective studies published from 10/12/2021 onwards in medical databases to assess clinical efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Piechotta, Vanessa, Mellinghoff, Sibylle C., Hirsch, Caroline, Brinkmann, Alice, Iannizzi, Claire, Kreuzberger, Nina, Adams, Anne, Monsef, Ina, Stemler, Jannik, Cornely, Oliver A., Bröckelmann, Paul J., Skoetz, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152308/
https://www.ncbi.nlm.nih.gov/pubmed/35641489
http://dx.doi.org/10.1038/s41408-022-00684-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152308/
https://www.ncbi.nlm.nih.gov/pubmed/35641489
http://dx.doi.org/10.1038/s41408-022-00684-8

Ejemplares similares